Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 10;15(1):3083.
doi: 10.1038/s41467-024-47118-6.

The genomic evolutionary dynamics and global circulation patterns of respiratory syncytial virus

Collaborators, Affiliations

The genomic evolutionary dynamics and global circulation patterns of respiratory syncytial virus

Annefleur C Langedijk et al. Nat Commun. .

Abstract

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infection in young children and the second leading cause of infant death worldwide. While global circulation has been extensively studied for respiratory viruses such as seasonal influenza, and more recently also in great detail for SARS-CoV-2, a lack of global multi-annual sampling of complete RSV genomes limits our understanding of RSV molecular epidemiology. Here, we capitalise on the genomic surveillance by the INFORM-RSV study and apply phylodynamic approaches to uncover how selection and neutral epidemiological processes shape RSV diversity. Using complete viral genome sequences, we show similar patterns of site-specific diversifying selection among RSVA and RSVB and recover the imprint of non-neutral epidemic processes on their genealogies. Using a phylogeographic approach, we provide evidence for air travel governing the global patterns of RSVA and RSVB spread, which results in a considerable degree of phylogenetic mixing across countries. Our findings highlight the potential of systematic global RSV genomic surveillance for transforming our understanding of global RSV spread.

PubMed Disclaimer

Conflict of interest statement

L.J.B. has regular interaction with pharmaceutical and other industrial partners. He has not received personal fees or other personal benefits. U.M.C.U. has received major funding (>€100,000 per industrial partner) for investigator initiated studies from AbbVie, MedImmune, Janssen, the Bill and Melinda Gates Foundation, Nutricia (Danone) and MeMed Diagnostics. U.M.C.U. has received major cash or in kind funding as part of the public private partnership IMI-funded RESCEU project from GSK, Novavax, Janssen, AstraZeneca, Pfizer and Sanofi. U.M.C.U. has received major funding from Julius Clinical for participating in the INFORM-RSV study sponsored by AstraZeneca and Sanofi. U.M.C.U. has received minor funding for participation in trials by Regeneron and Janssen from 2015–2017 (total annual estimate less than €20,000). U.M.C.U. received minor funding for consultation and invited lectures by AbbVie, MedImmune, Ablynx, Bavaria Nordic, MabXience, Novavax, Pfizer, and Janssen (total annual estimate less than €20,000). L.J.B. is the founding chairman of the ReSViNET Foundation. P.L. and M.A.S. acknowledge support from the European Union’s Horizon 2020 research and innovation programme (grant agreement no. 725422-ReservoirDOCS), from the Wellcome Trust through project 206298/Z/17/Z and from the NIH grant R01 AI153044. P.L. acknowledges support from the Research Foundation - Flanders (‘Fonds voor Wetenschappelijk Onderzoek - Vlaanderen’, G0D5117N and G051322N) and from the European Union’s Horizon 2020 project MOOD (grant agreement no. 874850). D.W. and E.J.K. are employees of AstraZeneca. The remaining authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Maximum likelihood reconstructions of RSVA (1482 genomes/taxa; 2006–2020) and RSVB (1543 genomes/taxa; 1997–2020) complete genome phylogenies and genotypes identification.
Lineages that are not assigned to a genotype are shown in light grey. The SH-aLRT and UFB support values for the genotypes are provided in Supplementary Table S1.
Fig. 2
Fig. 2. Posterior estimates of time-homogeneous predictor contributions to RSV diffusion between countries.
The predictors include the number of passengers travelling by air between each pair of countries represented in the data set (air travel, in dark red), population size at the origin and destination location (pop size ori & pop size dest, in blue), geographic distance (geo distance, in light green), absolute differences in latitude (lat diff, in dark orange) and sample sizes at the origin and destination locations (# taxa ori & # taxa dest, in dark green). The Y-axis represents the product of the coefficient (on a log scale) and the inclusion probability for the predictors (coefficient * Inclusion). (A, B: RSVA. C, D: RSVB. The plots on the left and right distinguish between analyses without and with sample size predictors respectively. E and F summarise the estimates for a single GLM-diffusion model applied to the combined RSVA and RSVB data sets at the country level. The grey boxes in the violin plots represent the median and quantile estimates. Violin plots are based on n = 507 (A), n = 535 (B), n = 45002 (C), n = 45002 (D), n = 452 (E) and n = 452 (F) post-burnin samples from the respective MCMC chains. Source data are provided as a Source Data file.
Fig. 3
Fig. 3. Posterior estimates of the normalised entropy for RSVA and RSVB phylogeographic clustering by country during the most recent season (2019–2020) of INFORM-RSV sampling.
The normalised entropy ranges between 0 (~no mixing of lineages by country) and 1 (~random mixing with respect to country). Circles and error bars refer to the mean and 95% Highest Posterior Density (HPD) interval of the normalised entropy estimates respectively. The size of the circles is proportional to what fraction of the highest mean estimate each average estimate represents. The same is indicated by the colours of the circles, which range from blue for an average estimate that represents 0% of the highest value to bright red for the highest mean estimate. Entropy estimates are based on n = 901 post-burnin samples from the stationary MCMC chain. Source data are provided as a Source Data file.

References

    1. Langedijk, A. C. & Bont, L. J. Respiratory syncytial virus infection and novel interventions. Nat. Rev. Microbiol., 10.1038/s41579-023-00919-w (2023). - PubMed
    1. Langedijk AC, et al. Global molecular diversity of RSV - the “INFORM RSV” study. BMC Infect. Dis. 2020;20:450. doi: 10.1186/s12879-020-05175-4. - DOI - PMC - PubMed
    1. Tan L, et al. Genetic variability among complete human respiratory syncytial virus subgroup A genomes: bridging molecular evolutionary dynamics and epidemiology. PLoS One. 2012;7:e51439. doi: 10.1371/journal.pone.0051439. - DOI - PMC - PubMed
    1. Bedford T, et al. Global circulation patterns of seasonal influenza viruses vary with antigenic drift. Nature. 2015;523:217–220. doi: 10.1038/nature14460. - DOI - PMC - PubMed
    1. Lemey P, et al. Unifying viral genetics and human transportation data to predict the global transmission dynamics of human influenza H3N2. PLoS Pathog. 2014;10:e1003932. doi: 10.1371/journal.ppat.1003932. - DOI - PMC - PubMed